← FDA Drug Approvals (Drugs@FDA)

NYSTATIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: PHARMOBEDIENT · Approved 1984-10-29

Drug application

FDA Application #

ANDA062512

Application type

Abbreviated New Drug Application (Generic)

Brand name

NYSTATIN

Generic name

NYSTATIN

Active ingredients

NYSTATIN

Dosage form

SUSPENSION

Route

ORAL

Marketing status

Prescription

Sponsor

PHARMOBEDIENT

Manufacturer

Xttrium Laboratories, Inc.

First approval

1984-10-29

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown